New shot aims to shield cancer patients from Chemo's dangerous side effect
Disease control
Ongoing
This study is testing a new, longer-lasting injection to prevent a dangerous drop in white blood cells (neutropenia) after chemotherapy. It involves 250 women with breast cancer and compares the new injection to an existing standard treatment. The goal is to see if the new versio…
Phase: PHASE3 • Sponsor: Kexing Biopharm Co., Ltd. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC